NCT06451614 2026-04-16
HYDROSPACE
Boston Scientific Corporation
Phase NA Active not recruiting
Clinical Trials
312 trialsNCT07042620 2026-04-16
A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
SonoClear AS
Phase NA Recruiting
NCT07534813 2026-04-16
A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors
Grit Biotechnology
Phase NA Not yet recruiting
NCT04905069 2026-04-15
SABRE
Boston Scientific Corporation
Phase NA Active not recruiting
NCT05635929 2026-04-15
STOPOMP
Mucosa Innovations, S.L.
Phase NA Recruiting
NCT06511141 2026-04-15
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Axonics, Inc.
Phase NA Recruiting
NCT07287176 2026-04-15
PRECISE-BTN
Pulse Biosciences, Inc.
Phase NA Recruiting
NCT07337590 2026-04-15
ASSURE
Exero Medical Ltd.
Phase NA Recruiting
NCT07530133 2026-04-15
Clinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery
Hangzhou Kangji Weijing Medical Robotics Co., Ltd.
Phase NA Not yet recruiting
NCT05611632 2026-04-14
NHS-Galleri
GRAIL, Inc.
Phase NA Active not recruiting
NCT05847166 2026-04-14
A Phase 2/3,PSMA-T4, Prostate Cancer
NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom
Phase NA Recruiting
NCT06453057 2026-04-14
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours
Grit Biotechnology
Phase NA Recruiting
NCT06819280 2026-04-14
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer
Grit Biotechnology
Phase NA Recruiting
NCT02718001 2026-04-13
Edwards EVOQUE Eos MISCEND Study
Edwards Lifesciences
Phase NA Active not recruiting
NCT04988750 2026-04-13
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
NaviFUS Corporation
Phase NA Completed
NCT05155605 2026-04-13
PATHFINDER 2: A Multi-Cancer Early Detection Study
GRAIL, Inc.
Phase NA Active not recruiting
NCT05683691 2026-04-13
VAPOR 2
Francis Medical Inc.
Phase NA Active not recruiting
NCT06940648 2026-04-13
VIABLE
Virtuoso Surgical, Inc.
Phase NA Enrolling by invitation
NCT07276529 2026-04-13
Colonic
GI Windows, Inc.
Phase NA Recruiting
NCT07296263 2026-04-13
Contrast PMR
Hyperfine
Phase NA Enrolling by invitation
NCT04446416 2026-04-09
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
Phase NA Completed
NCT06902402 2026-04-09
Evaluation of Safety and Efficacy of Three Flavors of Supportan® Drink in Cancer Patients in Taiwan
Fresenius Kabi Taiwan Ltd.
Phase NA Completed
NCT07291973 2026-04-09
AURORA
Endowave Ltd.
Phase NA Recruiting
NCT07214532 2026-04-08
SIGNAL-ER 101
Natera, Inc.
Phase NA Recruiting
NCT06020573 2026-04-07
Evaluation of Safety and Performance of Intraoperative Detection of Light Signals During Electrosurgical Breast Cancer Resection
Erbe Elektromedizin GmbH
Phase NA Completed
NCT06754722 2026-04-07
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
5 Point App, Inc.
Phase NA Recruiting
NCT07488585 2026-04-07
THYMAL 01
Sound Blade Medical Inc.
Phase NA Not yet recruiting
NCT07492381 2026-04-07
A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer
ALPFA Medical
Phase NA Not yet recruiting
NCT03737734 2026-04-06
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Active not recruiting
NCT04582656 2026-04-06
VIOLETTE
Koelis
Phase NA Completed
NCT05047094 2026-04-06
Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT05781555 2026-04-06
Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT05899985 2026-04-06
MAGMAP
Ferronova Pty Ltd
Phase NA Active not recruiting
NCT06308120 2026-04-06
ARTICULAtE
Intuitive Surgical
Phase NA Active not recruiting
NCT06698458 2026-04-06
Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT06910306 2026-04-06
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT07290998 2026-04-06
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer
Alpha Tau Medical LTD.
Phase NA Not yet recruiting
NCT06651632 2026-03-31
WATER IV PCa
PROCEPT BioRobotics
Phase NA Recruiting
NCT04471844 2026-03-30
EF-32
NovoCure Ltd.
Phase NA Completed
NCT06453642 2026-03-30
GPX
Fluidx Medical Technology, Inc.
Phase NA Active not recruiting
NCT07377487 2026-03-30
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT07501442 2026-03-30
Clinical Trial Evaluating the Efficacy and Safety of Uracil 0,5% Plasters in Oncology Patients Affected by Hand-foot Syndrome (HFS)
Wooshin Labottach Co., Ltd.
Phase NA Not yet recruiting
NCT05188573 2026-03-27
EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients
ClearNote Health
Phase NA Withdrawn
NCT06192758 2026-03-27
VOYAGER
Boston Scientific Corporation
Phase NA Active not recruiting
NCT07219797 2026-03-25
Study of Monochromatic X-ray Mammography System
Imagine Scientific, Inc.
Phase NA Not yet recruiting
NCT07492173 2026-03-25
Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans
Shandong New Time Pharmaceutical Co., LTD
Phase NA Completed
NCT06206746 2026-03-24
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
May Health
Phase NA Recruiting
NCT06699875 2026-03-23
Conventional Therapy vs. Telerehabilitation With TRAK in Patients Undergoing Axillary Lymph Node Removal
Trak Health Solutions S.L.
Phase NA Completed
NCT07487064 2026-03-23
TARGET
Galvanize Therapeutics, Inc.
Phase NA Recruiting
NCT03551249 2026-03-20
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
InSightec
Phase NA Completed